Skip to main content

Table 2 Clinical, laboratory, and ART information of HIV infected children receiving ART in Amhara Region Referral Hospitals from January 1, 2012 to February 28, 2017

From: Mortality rate among HIV-positive children on ART in Northwest Ethiopia: a historical cohort study

Variables

Frequency (N)

Percentage (%)

OI at baseline

 Yes

242

45.0

 No

296

55.0

Functional status (age 5 years) (N = 347)

 Working

195

56.2

 Ambulatory

144

41.5

 Bedridden

8

2.3

Developmental history (age < 5 years) (N = 191)

  

 Appropriate

143

74.9

 Delayed

40

20.9

 Regressive

8

4.2

WHO clinical staging

 Stage I and II

310

57.6

 Stage III and IV

228

42.4

Past TB test before ART

  

 Not determined

430

80.0

 Negative

53

9.9

 Positive

55

10.1

Past TB treatment

 No treatment

483

89.8

 2SRHZ/4RH

38

7.1

 2HRZES/4HRE

4

0.8

 HRZE/4RH

13

2.4

CD4 count or percent

 Severe immunodeficiency

374

69.5

 Mild immunodeficiency

164

30.5

Hemoglobin level

 Anemic(< 10 g/dl)

66

12.3

 Non-anemic (≥10 g/dl)

472

87.7

ART eligibility criteria

 Immunologic/ CD4

134

24.9

 WHO clinical stage

67

12.5

 Both clinical and immunologic

216

40.2

 Test and treat approach

121

22.5

Cotrimoxazole preventive therapy

 Yes

340

63.2

 No

198

36.8

ART adherence in the 1st 3 months

 Good /fair

495

92.2

 Poor

42

7.8

Underweight (baseline)

 Normal

317

58.9

 Moderate (WAZ < - 2)

128

23.8

 Severe (WAZ < −3)

93

17.3

Stunting (baseline)

 Normal

336

62.5

 Moderate (HAZ < −2)

80

14.9

 Severe (HAZ < −3)

122

22.7

Wasting (baseline)

 Normal

365

67.8

 Moderate (WHZ or BAZ < −2)

83

15.4

 Severe (WHZ or BAZ < − 3)

90

16.7